Edition:
United States

Dr.Reddy's Laboratories Ltd (REDY.BO)

REDY.BO on Bombay Stock Exchange

2,053.90INR
1:10am EDT
Change (% chg)

Rs23.00 (+1.13%)
Prev Close
Rs2,030.90
Open
Rs2,025.00
Day's High
Rs2,059.95
Day's Low
Rs2,017.20
Volume
106,120
Avg. Vol
102,338
52-wk High
Rs2,788.00
52-wk Low
Rs1,888.00

Chart for

About

Dr. Reddy's Laboratories Limited is a pharmaceutical company that is engaged in providing medicines. The Company operates in three segments: Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Proprietary Products. The Global Generics segment includes manufacturing and marketing prescription and... (more)

Overall

Beta: 0.02
Market Cap(Mil.): Rs342,895.91
Shares Outstanding(Mil.): 166.00
Dividend: 20.00
Yield (%): 0.97

Financials

  REDY.BO Industry Sector
P/E (TTM): 36.27 28.88 32.86
EPS (TTM): 56.96 -- --
ROI: 6.28 13.55 13.13
ROE: 7.63 15.28 15.07

Indivior warning on anti-opioid drug competition sends shares tumbling

British drugmaker Indivior warned on Wednesday it would miss its full-year profit target as its best-selling opioid addiction drug faces new competitors in the United States, sending its shares down 37 percent.

Jul 16 2018

Indivior's shares jump 30 pct after U.S. court blocks sale of rival generic

July 16 Indivior Plc's shares soared as much as 30 percent on Monday after a U.S. court blocked India's Dr.Reddy's Laboratories from selling copycat versions of the British drugmaker's bestselling opioid addiction treatment in the United States.

Jul 16 2018

UPDATE 2-Indivior warning on anti-opioid drug competition sends shares tumbling

* Best-seller's rapid market share loss to hit revenue by $25 mln

Jul 11 2018

UPDATE 2-Indivior gets breather after court extends order blocking generic rival

* Update on Sublocade will be key to sentiment-Jefferies (Adds share move, analyst comments)

Jun 29 2018

Indian shares post fourth straight weekly gain; Infosys, TCS boost

* NSE index ended 0.09 pct higher, BSE index closed up 0.06 pct

Jun 15 2018

Indian shares close slightly higher; SBI, Dr.Reddy's gain on Q4 results

May 22 Indian shares ended slightly higher on Tuesday, driven by gains in Dr. Reddy's Laboratories Ltd and State Bank of India (SBI) following their quarterly results.

May 22 2018

UPDATE 1-India's Dr. Reddy's Q4 profit falls 19 pct on U.S. headwinds

May 22 Indian generic drugmaker Dr. Reddy's Laboratories Ltd posted a 19 percent drop in quarterly net profit on Tuesday, missing analysts' estimates, pulled down by headwinds in the U.S. market.

May 22 2018

CORRECTED-India's Dr. Reddy's Q4 profit falls about 19 pct, misses estimates

May 22 Indian generic drugmaker Dr. Reddy's Laboratories Ltd posted an about 19 percent fall in quarterly net profit, missing estimates, hurt by headwinds in the U.S. market.

May 22 2018

BRIEF-Dr.Reddy's Labs Gets EIR From USFDA For API Mirfield Plant, UK

* GETS ESTABLISHMENT INSPECTION REPORT FROM US FDA FOR API MIRFIELD PLANT, UK Source text for Eikon: Further company coverage:

Apr 24 2018

BRIEF-Dr.Reddy's Laboratories Gets EIR From US FDA For API Cuernavaca Plant In Mexico

* SAYS GETS EIR FROM US FDA FOR API CUERNAVACA PLANT IN MEXICO Source text: https://bit.ly/2H9URmM Further company coverage:

Apr 10 2018

Earnings vs. Estimates